ArticleOncogene2019
B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
Hongyu Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleOncogene2019
Hongyu Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.